A systematic review of cost-effectiveness modeling of pharmaceutical therapies in neuropathic pain: variation in practice, key challenges, and recommendations for the future-Reference-Cited by-同舟云学术

A systematic review of cost-effectiveness modeling of pharmaceutical therapies in neuropathic pain: variation in practice, key challenges, and recommendations for the future

Published:2016-09-16 Issue:2 Volume:20 Page:129-139
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Critchlow Simone¹,Hirst Matthew²,Akehurst Ron¹,Phillips Ceri³,Philips Zoe¹,Sullivan Will¹,Dunlop Will C.N.²

Affiliation:

1. BresMed Health Solutions, Sheffield, UK;

2. Mundipharma International, Cambridge, UK;

3. Swansea University, Swansea, Wales, UK

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2016.1229671

Reference48 articles.

1. Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update

2. International Association for the Study of Pain (IASP). IASP Taxonomy. 2015. http://www.iasp-pain.org/Taxonomy#Neuropathicpain. Last Accessed: August 17, 2015

3. A Cost-Effectiveness Analysis of the Effect of Pregabalin Versus Usual Care in the Treatment of Refractory Neuropathic Pain in Routine Medical Practice in Spain

4. A cost-utility study of the use of pregabalin in treatment-refractory neuropathic pain

5. National Institute for Health and Care Excellence (NICE). NICE guideline CG173: Neuropathic pain - pharmacological management. 2013. http://guidance.nice.org.uk/CG173/NICEGuidance/pdf/English. Last Accessed August 17, 2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treadmill running on neuropathic pain: via modulation of neuroinflammation;Frontiers in Molecular Neuroscience;2024-06-26

2. Off‐label pharmacological treatment for neuropathic pain: A Delphi study by the Spanish Pain Society Neuropathic Pain Task Force;Pain Practice;2022-11-12

3. Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models;Journal of Medical Economics;2020-01-11

4. Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis;PLOS ONE;2019-05-30

5. Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review;PharmacoEconomics;2019-01-14